Nuvalent (NUVL)
NASDAQ:NUVL
Want to see NUVL full AI Analyst Report?
Comparison Results
Cytokinetics
$66.71
$9.31B
-9.86
162.13%
16 Buy
3 Hold
0 Sell
Strong Buy
Axsome Therapeutics
$188.99
$11.53B
-33.52
124.05%
18 Buy
1 Hold
0 Sell
Strong Buy
Atrium Therapeutics, Inc.
$14.41
$224.88M
-2.17
-10.03%
1 Buy
0 Hold
0 Sell
Moderate Buy
Performance Comparison
NUVL
Nuvalent
104.41
33.41
47.06%
CYTK
Cytokinetics
78.64
48.80
163.54%
TGTX
TG Therapeutics
40.79
7.20
21.43%
AXSM
Axsome Therapeutics
232.27
125.05
116.63%
MRUS
―
―
―
―
RNA
Atrium Therapeutics, Inc.
13.27
-1.48
-10.03%